Skip to main content

Oleg Nodelman

Equibles does not estimate personal net worth.

Get an email with a short summary when Anaptysbio, Inc publishes a filing, an earnings call transcript or a press release.

Get ANAB alerts

About Oleg Nodelman

Oleg Nodelman is recorded as Board Member at Anaptysbio, Inc (ANAB). The newest filing on record that lists Oleg Nodelman as Board Member at Anaptysbio, Inc (ANAB) is dated June 29, 2026. Aktis Oncology, Inc. reported in an 8-K filed April 16, 2026 that Oleg Nodelman resigned as member of the Board and all committees thereof, effective May 20, 2026. The same filing states: “Ms. Kim and Mr. Nodelman’s resignations are not due to any disagreement with the Company relating to any of the Company’s operations, policies or practices.” Anaptysbio, Inc reported in an 8-K filed April 12, 2021 that Oleg Nodelman was appointed Class I director, effective April 8, 2021. Anaptysbio, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anaptysbio, Inc includes Daniel Faga (CEO and Board Member), John Orwin (Chairman and Board Member), Ajim Tamboli (CFO) and 7 others.

“On April 15, 2026, each of Helen S. Kim and Oleg Nodelman notified the Board of their decision to resign from their respective positions as members of the Board and all committees thereof, effective as of May 20, 2026.”
“Ms. Kim and Mr. Nodelman’s resignations are not due to any disagreement with the Company relating to any of the Company’s operations, policies or practices.”
Aktis Oncology, Inc. Form 8-K, filed April 16, 2026 · Read the filing
“On April 8, 2021, AnaptysBio, Inc. \(the “Company”\) appointed Oleg Nodelman as a Class I director on its board of directors \(the “Board”\), effective immediately.”
Anaptysbio, Inc Form 8-K, filed April 12, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Anaptysbio, Inc

Recent activity